A contemporary evaluation of surgical aortic valve replacement outcomes and temporal trends

Abstract

AbstractBackgroundGiven the ageing population and uptake of transcatheter approaches for treating aortic stenosis (AS), a renewed evaluation of outcomes after surgical aortic valve replacement (SAVR) is warranted. With guidelines recommending age‐based indications for surgical and transcatheter approaches, this study critically evaluates outcomes in age‐based subgroups, with the aim to refine management of AS in the elderly, where there is often no clear consensus.MethodsSix hundred and thirteen consecutive patients who underwent SAVR in an Australian tertiary cardiac centre between 1 June 2014 and 13 January 2022 were retrospectively analysed. Of these, 70.31% were <75 years (Group 1) and 29.69% were ≥75 years (Group 2). Groups were compared with respect to early and long‐term outcomes. Logistic regression, Kaplan–Meier survival estimates and Cox proportional hazards regression were performed for all patients and an AS‐specific sub‐group.ResultsPatients aged ≥75 years were more likely to be female and have hypercholesterolemia, hypertension, and pre‐existing arrhythmia (P < 0.001). Group 1 experienced a higher incidence of renal failure compared with Group 2, in the overall cohort and AS‐specific subgroup (P = 0.02). The incidence of stroke was similar between groups, in the overall cohort (P = 0.22) and the AS‐specific subgroup (P = 0.32). Age ≥ 75 was not found to be an independent predictor of 30‐day, 1‐year or 5‐year mortality. Temporal trends revealed low consistently low complication rates.ConclusionsElderly patients should not be denied surgery based on age, despite guideline‐driven age‐based recommendations.